A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia

NCT00060502 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Cachexia
Pancreatic Neoplasms

Interventions

DRUG: Infliximab; Gemcitabine

Sponsor

Centocor, Inc.